top of page
Aton Biotech - A Henlius Company

Accelerate your molecule to market through an experienced CDMO partner of choice!

Aton Biotech - A Henlius Company is the fast-growing CDMO company which is committed to enabling new biological drugs for clients with an integrated bio-pharmaceutical platform. Our service ranges from cell line development to clinical and end-to-end CDMO commercial manufacturing services, including development of mammalian expressed monoclonal antibodies, fusion proteins, bispecific antibodies, ADC, etc.


Aton Biotech has two R&D &manufacturing sites in Shanghai. Both are equipped with the latest technology and fully compliant with the cGMP requirement of the NMPA, EMA and FDA.


Trust an experienced CDMO partner of choice with:

30+ Molecules (mAb, BsAb, fusion protein, ADC, etc.)

50+ IND Approvals (USA, China, etc.)

100% Tech Transfer success Rate

100+ Tox and Clinical Batch Production

450+ Commercial Batch Production


Learn more by visiting us: 

Contact us: 


Thank you.


Min Park

Chief Business Officer

Aton Biotech - A Henlius Company

Min Park

Service Provider:

USA Europe China Other areas Japan CDMO Biologics Preclinical Clinical On the Market

Demand Type:

Looking for biotech/pharma


December 31, 2024

Back to Business

bottom of page